B. Charreau et al., PROTECTION OF RAT ENDOTHELIAL-CELLS FROM PRIMATE COMPLEMENT-MEDIATED LYSIS BY EXPRESSION OF HUMAN CD59 AND OR DECAY-ACCELERATING FACTOR/, Transplantation, 58(11), 1994, pp. 1222-1229
The present study analyzed the ability of human decay-accelerating fac
tor (DAF) and CD59 to protect rat endothelial cell (EC) clones from hu
man and primate complement-mediated lysis. By flow cytometry and Scatc
hard analysis, we show that human DAF and/or CD59 cDNAs under the tran
scriptional control of elongation factor 1-alpha promoter were express
ed at levels similar to or higher than that of a human EC line. Human
DAF and CD59 were released from the surface of transfected rat cells b
y phosphatidylinositol phospholipase C, demonstrating that the two mol
ecules were linked to the cell membrane by means of a glycolipid ancho
r. The functional activity of the two human C regulatory proteins expr
essed on rat EC lines was studied using an in vitro assay of C-depende
nt cytotoxic in which rat EC were incubated with human or nonhuman pri
mate sera as sources of xenogeneic natural antibodies and C. We demons
trate that human and monkey xenogeneic natural antibodies bind to rat
cells and induce lysis by a C-dependent mechanism involving mainly the
C direct activation pathway. Our data indicate that human DAF and CD5
9, expressed either alone or in combination, abrogated all EC cytotoxi
city, even in the presence of 50% human serum. This protective phenoty
pe was correlated with decreased membrane attack complex (CD59 and/or
DAF transfectants) and C3 deposition (DAF transfectants) on EC surface
. Antibodies against the transfected molecules abolished the protectio
n against C-mediated lysis.